PMID: 42170981
Short-term comparative effects of semaglutide, either alone or in conjunction with canagliflozin, on early diabetic kidney disease.
Long Wang, Ningning Li, Weijun Huang
Pakistan journal of pharmaceutical sciences · 2026
Vol. 39, Issue 7, pp. 2165-2172
This entry links to third-party literature. For research use only.
HumansGlucagon-Like PeptidesMaleDiabetic NephropathiesFemaleMiddle AgedCanagliflozinDrug Therapy, CombinationDiabetes Mellitus, Type 2Blood Glucose